| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |